A compound formula for reducing the activity of a cervical cancer cell in a subject is provided. The compound formula includes at least one compound selected from the group consisting of baicalein, baicalin, berberine hydrochloride, and derivatives thereof, and at least one compound selected from the group consisting of isopsoralen, triptolide, quercetin, gossypol-acetic acid, and derivatives thereof.用以減低子宮頸癌細胞活性之複方組合物,上述複方組合物包含至少兩種化合物,其中一種為黃芩素、黃芩苷、鹽酸小蘖鹼與其衍生物其中之一,另一種為補骨脂素、雷公藤內酯、槲皮素、棉酚醋酸酯與其衍生物其中之一。
